Effect of Perioperative Glutamine Supplementation on Acute Kidney Injury in Infants Undergoing Elective Cardiac Surgery: A Randomized Controlled Trial
Objective: Acute kidney injury (AKI) is a frequent and serious complication in infants after cardiac surgery. Glutamine (GLN), a conditionally essential amino acid, has demonstrated renoprotective potential in animal models and has been shown to attenuate biomarkers of kidney damage in high-risk patients undergoing cardiac surgery. However, whether these renoprotective benefits extend to pediatric patients remains unknown. Methods: We conducted a single-center, randomized, double-blind, placebo-controlled trial in infants and young children younger than 3 years undergoing cardiac surgery with cardiopulmonary bypass. Ninety-four patients were randomly assigned to receive intravenous alanyl-glutamine (0.4 g/kg/day, n = 47) or 0.9% saline placebo (n = 47), administered from anesthesia induction and continued for 4 consecutive days (the day of surgery and the first 3 postoperative days). The primary outcome was the incidence of AKI within 72 h postoperatively, defined according to the KDIGO criteria. Secondary outcomes included the requirement for peritoneal dialysis (PD), diuretic use, serum creatinine (Scr), neutrophil gelatinase-associated lipocalin (NGAL), cystatin C, procalcitonin, and the lengths of ICU and hospital stay. Results: The incidence of KDIGO-defined AKI was lower in the GLN group than in the control group (14.9% vs. 40.4%; p = 0.010). Among the prespecified secondary outcomes, the requirement for PD (0% vs. 12.8%; p = 0.026) and diuretic use (6.4% vs. 23.4%; p = 0.040) were also lower in the GLN group. Postoperative NGAL concentrations were lower in the GLN group at 24, 48, and 72 h (p < 0.050 for each time point). No significant differences were observed in the lengths of ICU or hospital stay. Conclusions: In this single-center trial, perioperative GLN supplementation was associated with a lower incidence of postoperative AKI, a lower requirement for PD, and less diuretic use in infants undergoing elective cardiac surgery. These exploratory findings support a possible renoprotective role for GLN in this high-risk population but require confirmation in larger multicenter trials before adoption into clinical practice.
Authors
- Wenjun Qin (ORCID: https://orcid.org/0000-0002-8394-9240)
- Haifa Hong (ORCID: https://orcid.org/0000-0002-3418-793X)
- Li Wang (ORCID: https://orcid.org/0000-0002-4706-2482)
- Xiaobing Li
- Jia Li
Institutions
- Shanghai Children's Hospital (CN)
Publication Details
- Journal
- Nutrients
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/nu18223859
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00